DoubleDown Interactive Announces Upcoming Conference Participation

SEATTLE, May 11, 2022 (GLOBE NEWSWIRE) -- DoubleDown Interactive (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital social casino games, today announced its participation in the 17^th Annual Needham Technology & Media Conference and the 22^nd Annual B. Riley Institutional Investor Conference.

17^th Annual Needham Technology & Media Conference
The 17^th Annual Needham Technology & Media Conference is being held virtually and in New York, New York May 16-18, 2022. DoubleDown management will be hosting one-on-one meetings with investors and management is scheduled to present on May 16, 2022 at 11:45 a.m. Eastern Time. Those interested in attending the presentation may join here and a replay will be available in the Investor Relations section of the Company’s website.

22^nd Annual B. Riley Institutional Investor Conference
The 22^nd Annual B. Riley Institutional Investor Conference is being held in Los Angeles, California May 25-26, 2022. DoubleDown management will be hosting one-on-one meetings with investors and management is scheduled to present on May 26, 2022 at 4:40 p.m. Eastern Time.

About DoubleDown Interactive
DoubleDown Interactive, Co. Ltd. is a leading developer and publisher of digital games on mobile and web-based platforms. We are the creators of multi-format interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. Our flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games.

Company Contact:
Joe Sigrist
[email protected]
+1 (206) 773-2266
Chief Financial Officer
https://www.doubledowninteractive.com

Investor Relations Contact:
Cody Slach or Jeff Grampp, CFA
Gateway Group
1-949-574-3860
[email protected]

You May Also Be Interested In

• Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Ann
• MAX Power Announces Special Meeting of Shareholders and Completion of Warrant Exercise for Total Proceeds of $3.75 Million
• Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank